Recent Comments

Researchers discover protein that stimulates production of beta-amyloid (1)
Kent wrote: We at the Fisher Center for Alzheimer’s Research F… [More]
World becoming numb to HIV/AIDS: UNAIDS executive director (1)
James_Mac wrote: Part of the issue is the falling credibility of UN… [More]
Sangart reports positive data from MP4OX Phase IIa study in trauma patients (1)
dpwoelke wrote: Sangart's MP4 is just the same tired old Alliance … [More]
Plant sterols to lower cholesterol have risks (1)
John Brunsden wrote: Several months ago I started bicycle exercise. I e… [More]
Accuray receives Shonin approval to market CyberKnife G4 Robotic Radiosurgery System (1)
Marie-Lou Lizotte-Buisson wrote: Dear editor, My name is Marie-Lou Lizotte-Buiss… [More]
Anti-smoking measures beefed up (1)
Quitober wrote: What amazes me is that no state or federal governm… [More]
Physicians of New York Walk In Medical Group open new center in New York City (1)
Tyler wrote: DO NOT trust New York Walk In Medical. The doctor … [More]

<< FDA's 5-year NCE exclusivity grant to VYVANSE: Court upholds decision | Second AACR cancer research conference to be hosted in Dead Sea, Jordan >>

KAPIDEX to be marketed as DEXILANT in the U.S.

5. March 2010 01:26

Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

Continued on Next page >>

Biogen, Elan launch My MS Health, a web-based PRO research programBiogen Idec and Elan Corporation, plc, in collaboration with EPI-Q, Inc. and Avatar International, L...Community-wide wellness initiative to deliver preventive health care services to northwest ArkansasU.S. Preventive Medicine® and Washington Regional Medical Center, together with Arkansas Occupationa...PATH praises Gates Foundation for supporting vaccine development and deliveryVaccination may be the most effective public health intervention of all time-especially in low-incom...FDA approves Santarus’ NDA for immediate-release prescription tablet productSantarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug A...ARYx Therapeutics announces operating results for the third quarter of 2009ARYx Therapeutics, Inc. today reported results of operations and provided a general business update ...CombinatoRx announces Synavive Phase 2 extension trial results at the 2009 ACR meetingCombinatoRx, Incorporated today announced the results of a 12 month knee osteoarthritis (OA) Phase 2...Disposable Grind-No-More dental night protector launched by PlackersPlackers(R), makers of the first disposable dental flosser, expands its line of convenient home dent...Meda launches EDLUAR in the U.S.Meda Pharmaceuticals Inc. (Meda) today announced the commercial availability of EDLUAR(TM) (zolpidem...Insomnia and short sleep combination a risk factor for hypertensionA study in the April 1 issue of the journal SLEEP is the first to demonstrate that chronic insomnia ...FDA approves new indication for Wyeth's Tygacil (tigecycline)Wyeth Pharmaceuticals, a division of Wyeth has announced that the U.S. Food and Drug Administration ...FDA approves tapentadol immediate-release tablets for pain in adultsMillions of Americans with moderate to severe acute pain and their health-care providers will soon h...Neglect or abuse in childhood linked to adult inflammation, depressionA history of neglect or abuse in childhood appears to be associated with depression and inflammation...Researchers have developed an animal model of infantile spasmsResearchers have developed an animal model of infantile spasms, improving the likelihood of finding ...Precautions against C. difficile infectionIllness related to C. difficile, a bacterium commonly found in hospitals, is becoming more widesprea...Simpler and less expensive method of controlling the progression of HIVThere might be a simpler and less expensive method of controlling the progression of HIV, according ...German scientists synthesize new compound that reduces stroke damageA group of German scientists has synthesized a new compound that dramatically decreases the damage t...Evolutionary biology research predicts precancerous tumorsIn diverse ecosystems, packed with wildly different species, evolution whizzes along. As different s...Contrary to common wisdom, sleeping pills may not increase fall riskIn nursing homes across the country, elderly people with insomnia often go untreated, because of the...Treatment to control gastroesophageal reflux disease in children found to be ineffectiveAccording to a study published in the American Gastroenterological Association (AGA) journal Clinica...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Free!

Recent Comments

Twitter

Information

KAPIDEX to be marketed as DEXILANT in the U.S.

Recent Articles

New Articles

Free!

Recent Comments

Twitter

Information

KAPIDEX to be marketed as DEXILANT in the U.S.

Medical News Cloud

Recent Articles

New Articles